Trygg Pharma AS – a company that will be jointly owned by Aker BioMarine ASA and an affiliate of Lindsay Goldberg LLC through a newly established joint venture company (cf. the separate notice of today) – has entered into an agreement to acquire 100% of the shares in Epax Holding AS (together with its subsidiaries “Epax”), a wholly owned subsidiary of Austevoll Seafood ASA. Epax is the world’s premier high concentrate omega-3 supplement manufacturer. Epax employs a total of 74 people.
In July 2013, FMC Corporation acquired Epax Nutra Holding III AS (Norway) and Epax UK Holding III AS (United Kingdom) (together, Epax)
The Norwegian Pelagic Fishing Course in Week 2 Norway
This winter's best week for NVG herring, and still a lot of mackerel from the west.
NVG herring:
We had the best week of the winter with as much as 31,700 tonnes in the record, where the bes...
The impact of catching half of Pacific saury Japan
The decline in the Pacific saury (Cololabis saira) fishery continues
Last year's national catch of saury or saury decreased by almost 30% from the previous year, reaching a record low for the secon...
Galicia: The «Brexit» begins to affect the port of Vigo Spain
The following is an excerpt from an article published by La Voz de Galicia:
Almost all the fish from the Gran Sol are reaching the city by road, but the obstacles to transporters push the shipowner...
Copyright 1995 - 2021 Fish Info & Services Co.Ltd| All Rights Reserved. DISCLAIMER
Trygg Pharma AS
Personal Profile
Shareholder companies:
Print
